Deregulated TGF-β superfamily signalling in cancer

Functions of BRCA1 and the implications for treatment

Resistance to CDK4/6 inhibitors

Deciphering the connection of genetics, immune infiltration and prognosis

Transforming patient care through translational research

Mechanisms of resistance to CDK4/6 inhibitors in triple negative breast cancer

pSTAT3 in luminal breast cancer - results from BIG-2-98 trial

Centrosomes in ovarian cancer

Hallmarks of cancer cell development

IDH metabolites induce a BRCAness that can be exploited by PARP inhibitors

Final overall survival analysis of MONARCH 1

Olaparib and temozolomide for relapsed small cell lung cancer